Abstracts tagged "rheumatoid arthritis (RA) and systemic sclerosis"

Abstract Number: 804 • 2016 ACR/ARHP Annual Meeting
Combined-Phenotype Meta-GWAS in Systemic Sclerosis and Rheumatoid Arthritis Identifies IRF4 As a New Common Susceptibility Locus
Elena Lopez-Isac¹, Shervin Assassi², Carmen Pilar Simeón³, Patricia Carreira⁴, Norberto Ortego Centeno⁵, Benjamin Fernandez Gutierrez⁶, Alejandro Balsa⁷, Miguel Angel González-Gay⁸, Lorenzo Beretta⁹, Claudio Lunardi¹⁰, Gianluca Moroncini¹¹, Torsten Witte¹², Nicolas Hunzelmann¹³, Joerg HW Distler¹⁴, Gabriela Riekemasten¹⁵, Annette HM van der Helm-van Mil¹⁶, Jeska K. de Vries-Bouwstra¹⁷, Cesar Magro-Checa¹⁸, Alexandre E. Voskuyl¹⁹, Madelon C. Vonk²⁰, Øyvind Molberg²¹, Tony Merriman²², Roger Hesselstrand²³, Annika Nordin²⁴, Leonid Padyukov²⁵, Ariane L. Herrick²⁶, Stephen Eyre²⁷, Christopher Denton²⁸, Carmen Fonseca²⁹, Timothy R.D.J. Radstake³⁰, Jane Worthington³¹, Maureen D Mayes² and Javier Martín¹, ¹Institute of Parasitology and Biomedicine López-Neyra, IPBLN-CSIC, Granada, Spain, ²Department of Internal Medicine - Rheumatology, University of Texas-McGovern Medical School, Houston, TX, ³Internal Medicine, Hospital Universitari Vall d'Hebron, Barcelona, Spain, ⁴Department of Rheumatology, Hospital Universitario 12 de Octubre, Madrid, Spain, ⁵Medicine Department, Hospital Universitario San Cecilio, Granada, Spain, ⁶Department of Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ⁷Department of Rheumatology, Hospital La Paz, Madrid, Spain, ⁸School of Medicine, University of Cantabria, Santander, Spain, ⁹Referral Center for Systemic Autoimmune Diseases, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico di Milano, Milan, Italy, ¹⁰Department of Medicine, Università degli Studi di Verona, Verona, Italy, ¹¹Dipartimento di Scienze mediche e Chirurgiche, Università politecnica delle Marche and Ospedali Riuniti, Ancona, Italy, ¹²Department of Clinical Immunology and Rheumatology, Hannover Medical School, Hannover, Germany, ¹³Department of Dermatology, University of Cologne, Cologne, Germany, ¹⁴Department of Internal Medicine 3 – Rheumatology and Immunology, Universitätsklinikum Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Erlangen, Germany, ¹⁵Department of Rheumatology, University of Lübeck, Luebeck, Germany, ¹⁶Rheumatology, Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ¹⁷Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, ¹⁸Department of Rheumatology, Leiden University Medical Center, Leiden, Spain, ¹⁹Rheumatology, Amsterdam Rheumatology and immunology Center, Location VU University Medical Center, Amsterdam, Netherlands, ²⁰Department of the Rheumatic Diseases, Radboud University Nijmegen Medical Centre, Nijmegen, Netherlands, ²¹Rheumatology, Oslo University Hospital, Oslo, Norway, ²²Department of Biochemistry, University of Otago, Otago, New Zealand, ²³Department of Rheumatology, Lund University, Lund, Sweden, ²⁴Department of Rheumatology, Karolinska Institute, Stockholm, Sweden, ²⁵Unit of Rheumatology, Department of Medicine, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden, ²⁶Centre for Musculoskeletal Research, University of Manchester, MAHSC, Salford Royal Hospital, Manchester, United Kingdom, ²⁷The University of Manchester, Manchester, United Kingdom, ²⁸Division of Medicine, Centre for Rheumatology and Connective Tissue Disease, University College London, London, United Kingdom, ²⁹Centre for Rheumatology, Royal Free and University College Medical School, London, United Kingdom, ³⁰Laboratory of Translational Immunology, UMC Utrecht, Utrecht, Netherlands, ³¹Arthritis Research UK Epidemiology Unit, Manchester Academic Health Science Centre, The University of Manchester, Manchester, United Kingdom
Background/Purpose: Genome-wide association studies (GWASs) have revolutionized our understanding of the genetic component of complex autoimmune diseases (ADs) by the identification of thousands of susceptibility…
Abstract Number: 2458 • 2016 ACR/ARHP Annual Meeting
Erectile Dysfunction in Men with Rheumatic Diseases: A Systematic Review
Omid Zahedi Niaki¹, Christian A. Pineau², Sasha Bernatsky^3,4 and Evelyne Vinet³, ¹Université de Montréal, Montreal, QC, Canada, ²McGill University Health Centre, Montreal, QC, Canada, ³Divisions of Rheumatology and Clinical Epidemiology, McGill University Health Centre, Montreal, QC, Canada, ⁴Clinical Epidemiology, Research Institute of the McGill University Health Centre, Montreal, QC, Canada
Background/Purpose: Given the obvious female predominance of rheumatic diseases, significant attention has already been drawn to the impact of these conditions on female sexual function.…
Abstract Number: 2892 • 2016 ACR/ARHP Annual Meeting
Serum Level of KL-6, a Biomarker of Interstitial Lung Disease (ILD), Is Higher in Diffuse SSc Than in Limited SSc and RA Even When the Activity of ILD Is Low
Tamao Nakashita¹, Shinji Motojima², Akira Jibatake², Akira Yoshida² and Yoshiki Yamamoto², ¹Department of Rheumatology and Allergy, Kameda Medical Center, Kamogawa-city, Japan, ²Department of Rheumatology and Allergy, Kameda Medical Center, Kamogawa city, Japan
Background/Purpose: KL-6 is a glycoprotein expressed on and released from type 2 alveolar cells and the measurement of KL-6 in serum was developed by Kohno…
Abstract Number: 2093 • 2013 ACR/ARHP Annual Meeting
A Comparison Of Performance On The Keital Functional Test By Persons With Rheumatoid Arthritis and Systemic Sclerosis
Janet L. Poole, Amy New and Christina Garcia, Occupational Therapy Program, University of New Mexico, Albuquerque, NM
Background/Purpose: Mobility is necessary for participation in all areas of daily life including self-care, work and leisure. In rheumatic conditions such as rheumatoid arthritis (RA)…
Abstract Number: 1785 • 2012 ACR/ARHP Annual Meeting
MiR-30* Family Negatively Regulates B-Cell Activating Factor (BAFF) Synthesis in Rheumatoid Synoviocytes
Ghada Alsaleh¹, Antoine Francois², Lucas Philippe¹, Jean Sibilia¹, Jacques-Eric Gottenberg¹, Philippe Georgel³ and Dominique Wachsmann¹, ¹Université de Strasbourg, EA4438 Laboratoire Physiopathologie des Arthrites, Illkirch-Strasbourg, France, ²Laboratory of Physiopathology of Arthritises, University of Strasbourg, Illkirch-Strasbourg, France, ³Université de Strasbourg, Laboratoire d'ImmunoGénétique Moléculaire Humaine, Strasbourg, France
Background/Purpose: In rheumatoid arthritis (RA) resident cells of the joint, fibroblast-like synoviocytes (RA FLS) acquire an aggressive phenotype in response to extrinsic factors such as…
Abstract Number: 1487 • 2012 ACR/ARHP Annual Meeting
Incidence of Fibromyalgia Syndrome in Systemic Sclerosis and Rheumatoid Arthritis. Comparative Results According to Clinical Diagnosis, Screening Test with Fibromyalgia Rapid Screening Tool, Diagnosis with ACR1990 and ACR 2010 Criteria
Serge Perrot¹, Mariana Peixoto², Philippe Dieude³, Eric Hachulla⁴, Sébastien Ottaviani⁵ and Yannick Allanore⁶, ¹Internal Medicine and Pain Clinic, Hopital Hotel Dieu, Paris, France, ²Rheumatology Department, Cochin Hospital, Paris, France, ³Rheumatology, Rheumatology departement & INSERM U699, Paris Diderot university, APHP, Bichat hospital, Paris, France, ⁴Department of Internal Medicine, Claude Huriez University Hospital, Lille, France, ⁵Service de Rhumatologie, Hôpital Bichat, APHP, APHP, Paris, France, ⁶Rheumatology, Paris Descartes University, Rheumatology A department, Cochin Hospital, Paris, France
Background/Purpose: Fibromyalgia (FMS) is a chronic widespread pain condition that may be associated with inflammatory chronic disorders like rheumatoid arthritis (RA) and systemic sclerosis (SSc).…

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].